01 17SUMITOMO PHARMA
01 27300935
02 28058280
03 18735401
04 19346822
05 110350170
06 110449191
07 110786501
08 111033551
09 111583526
10 111793812
11 211795178
12 111957684
13 112097198
14 112144809
01 6Y
02 11Blank
01 5Y
02 12Blank
01 12024-02-04
02 12024-02-17
03 42026-01-28
04 22033-09-27
05 12036-02-25
06 72037-09-29
07 12038-05-03
Patent Expiration Date : 2037-09-29
US Patent Number : 12144809
Drug Substance Claim :
Drug Product Claim :
Application Number : 214621
Patent Use Code : U-4035
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-09-29
Patent Expiration Date : 2037-09-29
US Patent Number : 11583526
Drug Substance Claim :
Drug Product Claim :
Application Number : 214621
Patent Use Code : U-3020
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-09-29
Patent Expiration Date : 2038-05-03
ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX
US Patent Number : 11793812
Drug Substance Claim :
Drug Product Claim :
Application Number : 214846
Patent Use Code : U-2360
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2038-05-03
Patent Expiration Date : 2037-09-29
US Patent Number : 12097198
Drug Substance Claim :
Drug Product Claim :
Application Number : 214621
Patent Use Code : U-3020
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-09-29
Patent Expiration Date : 2024-02-04
US Patent Number : 8735401
Drug Substance Claim :
Drug Product Claim :
Application Number : 214621
Patent Use Code : U-3019
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2024-02-04
Patent Expiration Date : 2037-09-29
US Patent Number : 10449191
Drug Substance Claim :
Drug Product Claim :
Application Number : 214621
Patent Use Code : U-3020
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-09-29
Patent Expiration Date : 2037-09-29
US Patent Number : 10786501
Drug Substance Claim :
Drug Product Claim :
Application Number : 214621
Patent Use Code : U-3020
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-09-29
Patent Expiration Date : 2024-02-17
ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX
US Patent Number : 9346822
Drug Substance Claim :
Drug Product Claim :
Application Number : 214846
Patent Use Code : U-3129
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2024-02-17
Patent Expiration Date : 2037-09-29
ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX
US Patent Number : 11033551
Drug Substance Claim :
Drug Product Claim :
Application Number : 214846
Patent Use Code : U-3129
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-09-29
Patent Expiration Date : 2037-09-29
ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX
US Patent Number : 11957684
Drug Substance Claim :
Drug Product Claim :
Application Number : 214846
Patent Use Code : U-3129
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-09-29
